Biodesix BDSX Ratios (2019-2026)

NASDAQ BDSX
$28.52 -2.08 (-6.80%)
As of: Aug 27, 2026 · 3:59 PM EDT
Reported Financials

Biodesix Quarterly Ratios

Periods 28 quarters
Latest Jun 2026

Biodesix reported a gross margin of 82.06% and a net margin of -27.44% for the quarter ended Jun 2026. These financial ratios cover 28 quarters of results from Sep 2019 through Jun 2026, standardized by Business Quant from the company’s SEC filings.

Ratios Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Profitability
Gross Margin
58.32%65.49%50.60%63.65%67.29%65.59%65.01%72.73%76.07%77.00%78.57%78.37%76.98%78.75%79.38%79.86%81.14%83.03%83.55%82.06%
EBT Margin
-224.12%-182.38%-238.21%-118.47%-122.89%-171.13%-207.20%-112.51%-70.85%-62.71%-91.44%-56.75%-58.58%-41.12%-60.26%-58.03%-41.92%-14.00%-32.00%-27.44%
EBIT Margin
-200.44%-161.67%-220.85%-106.17%-95.53%-144.58%-180.80%-92.04%-53.16%-46.84%-74.38%-45.95%-47.33%-32.55%-50.87%-48.55%-32.39%-6.84%-24.27%-20.06%
EBITDA Margin
-200.44%-161.67%-220.85%-106.17%-95.53%-144.58%-180.80%-92.04%-53.16%-46.84%-74.38%-45.95%-47.33%-32.55%-50.87%-48.55%-32.39%-6.84%-24.27%-20.06%
Operating Margin
-200.44%-161.67%-220.85%-106.17%-95.53%-144.58%-180.80%-92.04%-53.16%-46.84%-74.38%-45.95%-47.33%-32.55%-50.87%-48.55%-32.39%-6.84%-24.27%-20.06%
Net Margin
-224.12%-182.38%-238.21%-118.47%-122.89%-171.13%-207.20%-112.51%-70.85%-62.71%-91.44%-56.75%-58.58%-41.12%-60.26%-58.03%-41.92%-14.00%-32.00%-27.44%
FCF Margin
-134.04%-148.49%-192.93%-83.35%-134.23%-122.90%-169.63%-46.16%-71.75%-104.08%-104.91%-114.35%-60.06%-24.16%-48.31%-33.07%-41.01%2.41%-40.11%-1.65%
Efficiency
Assets AverageAssets Avg.
95.90M83.05M68.87M68.44M69.21M78.05M86.85M79.21M82.20M92.94M93.15M101.52M109.29M99.99M91.74M86.99M88.23M88.10M91.06M94.98M
Invested CapitalInvested Cap.
13.13M17.76M17.82M8.15M9.29M10.34M11.71M14.56M19.31M21.86M19.20M5.84M
Asset Utilization RatioAsset Util.
0.770.660.470.460.520.490.470.530.540.530.590.600.600.710.810.880.911.001.061.08
Leverage & Solvency
Interest Coverage RatioInterest Cover
-8.47-7.81-12.72-8.64-3.49-5.45-6.85-4.50-3.01-2.95-4.36-4.25-4.21-3.80-5.42-5.12-3.40-0.96-3.14-2.72
Debt Ratio
0.480.360.450.220.220.380.460.510.510.580.630.360.350.370.430.530.530.540.490.49
Times Interest Earned
-8.47-7.81-12.72-8.64-3.49-5.45-6.85-4.50-3.01-2.95-4.36-4.25-4.21-3.80-5.42-5.12-3.40-0.96-3.14-2.72
Valuation
Enterprise Value
-47.91M-32.81M-16.43M-23.69M-15.18M-43.09M-25.27M-17.41M-19.84M-26.28M-11.49M-42.22M-31.41M-26.25M-17.60M-20.73M-16.60M-18.99M-25.57M-30.00M
Return Ratios
Return on SalesROS
-0.02%-0.02%-0.02%-0.01%-0.01%-0.02%-0.02%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%-0.01%-0.01%0.00%0.00%0.00%0.00%
Return on Capital EmployedROCE
-43.65%-75.69%-127.53%-143.80%-152.13%-91.62%-81.08%-101.06%-97.59%-69.45%-58.12%-39.66%-36.04%-40.27%-41.58%-47.47%-46.45%-39.44%-32.57%-25.86%
Return on AssetsROA
0.00%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%-0.01%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%